ArticleCardiovascular diabetology2021

Thromboembolism, bleeding and vascular death in nonvalvular atrial fibrillation patients with type 2 diabetes receiving rivaroxaban or warfarin.

Craig I Coleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.